A1 Orlando Medical Corporation Consolidated Statements of Financial Position 1 December 31, 3 (In Millions) 2018 2017 Assets: Current Assets Cash and cash equivalents Short-term investments Accounts and notes receivable Inventories, at cost Prepaid expense and other current assets Total current assets $ 4,226 $ 4,333 845 6. 520 8. 3,400 433 2,403 411 1,226 10 1,638 10,649 1,555 6,804 303 $ 19,311 11 8,786 907 5,199 155 $ 15,047 12 Property and equipment, net 14 Other non-current assets 15 Total assets 16 Liabilities and stockholders' equity: Current liabilities Accounts payable Accrued and other liabilities 17 18 19 $ 7,708 3,676 11,384 304 1.701 13,389 $ 6,009 3,033 9,042 305 1.179 10,526 Total current liabilities 20 21 Long-term debt Other non-current liabilities 23 Total liabilities 24 Stockholders' equity 22 Preferred stock and capital in excess of $0.02 par value; 25 shares issued and outstanding: none Common stock and capital in excess of S0.05 par value; 28 26 27 shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost: 183 and 123 shares, respectively 29 7,803 (6,444) 4,676 (79) (34) 5,922 $ 19,311 7,001 (4,401) 1,990 (25) (44) 4,521 $ 15,047 30 31 Retained earnings 32 Other comprehensive loss 33 Other 34 Total stockholders' equity 35 Total liabilities and stockholders' equity 36 A1 Orlando Medical Corporation Consolidated Statements of Income 2 Year ended December 31, 3 (In Millions, Except per Share Amounts) 4 Net Revenue 5 Cost of goods sold 2018 $ 42,666 35,147 7,519 2016 $ 31,111 25,492 5,619 2017 $ 35,220 29,255 5,965 Gross profit 7 Operating expenses: 8. 6. Selling, general, and administrative Research, development, and engineering 10 3,341 544 3,250 553 2,985 536 512 4,033 1,586 (30) 1,556 472 $ 1.084 Special charges Total operating expenses. Operating income 11 12 13 Investment and other income (loss), net 14 3,885 3,634 153 3,787 1.136 $ 2,651 3,803 2,162 196 2,358 940 $ 1.418 Income before income taxes 15 Income tax expense 16 Net income 17 Earnings per common share: Basic 19 1.41 0.95 $ 0.37

FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
icon
Related questions
Question

During 2018, Orlando Medical’s total assets
a. increased by $1,863 million.
b. increased by 28.3%.
c. Both a and b.
d. increased by 22.1%

A1
Orlando Medical Corporation
Consolidated Statements of Financial Position
1
December 31,
3 (In Millions)
2018
2017
Assets:
Current Assets
Cash and cash equivalents
Short-term investments
Accounts and notes receivable
Inventories, at cost
Prepaid expense and other current assets
Total current assets
$ 4,226
$ 4,333
845
6.
520
8.
3,400
433
2,403
411
1,226
10
1,638
10,649
1,555
6,804
303
$ 19,311
11
8,786
907
5,199
155
$ 15,047
12 Property and equipment, net
14 Other non-current assets
15 Total assets
16 Liabilities and stockholders' equity:
Current liabilities
Accounts payable
Accrued and other liabilities
17
18
19
$ 7,708
3,676
11,384
304
1.701
13,389
$ 6,009
3,033
9,042
305
1.179
10,526
Total current liabilities
20
21
Long-term debt
Other non-current liabilities
23 Total liabilities
24 Stockholders' equity
22
Preferred stock and capital in excess of $0.02 par value;
25
shares issued and outstanding: none
Common stock and capital in excess of S0.05 par value;
28
26
27
shares authorized: 6,000; shares issued: 2,163 and
1,903, respectively
Treasury stock, at cost: 183 and 123 shares, respectively
29
7,803
(6,444)
4,676
(79)
(34)
5,922
$ 19,311
7,001
(4,401)
1,990
(25)
(44)
4,521
$ 15,047
30
31
Retained earnings
32
Other comprehensive loss
33
Other
34 Total stockholders' equity
35 Total liabilities and stockholders' equity
36
A1
Orlando Medical Corporation
Consolidated Statements of Income
2
Year ended December 31,
3 (In Millions, Except per Share Amounts)
4 Net Revenue
5 Cost of goods sold
2018
$ 42,666
35,147
7,519
2016
$ 31,111
25,492
5,619
2017
$ 35,220
29,255
5,965
Gross profit
7 Operating expenses:
8.
6.
Selling, general, and administrative
Research, development, and engineering
10
3,341
544
3,250
553
2,985
536
512
4,033
1,586
(30)
1,556
472
$ 1.084
Special charges
Total operating expenses.
Operating income
11
12
13 Investment and other income (loss), net
14
3,885
3,634
153
3,787
1.136
$ 2,651
3,803
2,162
196
2,358
940
$ 1.418
Income before income taxes
15 Income tax expense
16
Net income
17 Earnings per common share:
Basic
19
1.41
0.95
$ 0.37
Transcribed Image Text:A1 Orlando Medical Corporation Consolidated Statements of Financial Position 1 December 31, 3 (In Millions) 2018 2017 Assets: Current Assets Cash and cash equivalents Short-term investments Accounts and notes receivable Inventories, at cost Prepaid expense and other current assets Total current assets $ 4,226 $ 4,333 845 6. 520 8. 3,400 433 2,403 411 1,226 10 1,638 10,649 1,555 6,804 303 $ 19,311 11 8,786 907 5,199 155 $ 15,047 12 Property and equipment, net 14 Other non-current assets 15 Total assets 16 Liabilities and stockholders' equity: Current liabilities Accounts payable Accrued and other liabilities 17 18 19 $ 7,708 3,676 11,384 304 1.701 13,389 $ 6,009 3,033 9,042 305 1.179 10,526 Total current liabilities 20 21 Long-term debt Other non-current liabilities 23 Total liabilities 24 Stockholders' equity 22 Preferred stock and capital in excess of $0.02 par value; 25 shares issued and outstanding: none Common stock and capital in excess of S0.05 par value; 28 26 27 shares authorized: 6,000; shares issued: 2,163 and 1,903, respectively Treasury stock, at cost: 183 and 123 shares, respectively 29 7,803 (6,444) 4,676 (79) (34) 5,922 $ 19,311 7,001 (4,401) 1,990 (25) (44) 4,521 $ 15,047 30 31 Retained earnings 32 Other comprehensive loss 33 Other 34 Total stockholders' equity 35 Total liabilities and stockholders' equity 36 A1 Orlando Medical Corporation Consolidated Statements of Income 2 Year ended December 31, 3 (In Millions, Except per Share Amounts) 4 Net Revenue 5 Cost of goods sold 2018 $ 42,666 35,147 7,519 2016 $ 31,111 25,492 5,619 2017 $ 35,220 29,255 5,965 Gross profit 7 Operating expenses: 8. 6. Selling, general, and administrative Research, development, and engineering 10 3,341 544 3,250 553 2,985 536 512 4,033 1,586 (30) 1,556 472 $ 1.084 Special charges Total operating expenses. Operating income 11 12 13 Investment and other income (loss), net 14 3,885 3,634 153 3,787 1.136 $ 2,651 3,803 2,162 196 2,358 940 $ 1.418 Income before income taxes 15 Income tax expense 16 Net income 17 Earnings per common share: Basic 19 1.41 0.95 $ 0.37
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Forecasting Financial Statement
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education